For UK Healthcare Professionals only
For UK Healthcare Professionals only
Pre-registration is now available for our webinar which will be held on 19th September 2024: Opportunities and challenges of introducing an ustekinumab biosimilar to clinical practice.
Please enter your details in the form below and we’ll email you as soon as registration is open!
Adverse events should be reported to Thornton and Ross Limited by emailing thorntonross@medinformation.co.uk or by calling 01484 848164. Additionally, reporting forms and information can be found at: https://yellowcard.mhra.gov.uk or search for MHRA Yellow Card in the Google Play or Apple App Store.
UK-UZPRU-76 | July 2024